Cargando…

Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma

The association of hepatitis C virus (HCV) and B-cell non-Hodgkin lymphomas (NHL) has been highlighted by several epidemiological and biological insights; however the most convincing evidence is represented by interventional studies demonstrating the capability of antiviral treatment (AT) with inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merli, Michele, Carli, Giuseppe, Arcaini, Luca, Visco, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064026/ https://www.ncbi.nlm.nih.gov/pubmed/27784957 http://dx.doi.org/10.3748/wjg.v22.i38.8447

Ejemplares similares

Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy
por: Arcaini, Luca, et al.
Publicado: (2012)

Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus–Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi
por: Merli, Michele, et al.
Publicado: (2022)

Prognostic Assessment in Patients with Indolent B-Cell Lymphomas
por: Arcaini, Luca, et al.
Publicado: (2012)

Curative Effects for B-Cell Lymphoma Accomplished by Direct-Acting Antiviral Agents of Hepatitis C
por: Hattori, Nobuhiro, et al.
Publicado: (2017)

Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy
por: Galati, Giovanni, et al.
Publicado: (2016)

Primary hepatic large B-cell lymphoma following direct-acting antiviral treatment for hepatitis C
por: Zaimi, Yosra, et al.
Publicado: (2021)

Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy
por: Tasleem, Syed, et al.
Publicado: (2015)

Antiviral therapy in hepatitis C-infected patients prevents relapse of diffuse large B cell lymphoma
por: Pellicelli, Adriano, et al.
Publicado: (2018)

Treatment of indolent lymphoma
por: Jeong, Seong Hyun
Publicado: (2022)

Editorial: HBV and lymphoma
por: Gentile, Giuseppe, et al.
Publicado: (2023)

Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study
por: Morello, Lucia, et al.
Publicado: (2019)

Efficacy and prognosis of antiviral therapy on hepatitis C following treatment of lymphoma in HCV-positive diffuse large-cell lymphoma
por: Tsutsumi, Yutaka, et al.
Publicado: (2017)

Indolent T‐cell‐rich small B‐cell hepatic lymphoma in a Golden Retriever
por: Rout, Emily D., et al.
Publicado: (2018)

P1292: MOLECULAR CHARACTERIZATION OF DIFFUSE LARGE B-CELL LYMPHOMA ASSOCIATED TO HEPATITIS C VIRUS INFECTION
por: Sciarra, R., et al.
Publicado: (2022)

Cautious optimism in anticipation of hepatitis B curative therapies
por: Turshudzhyan, Alla, et al.
Publicado: (2022)

The comparison of different antiviral therapies on the prognosis of hepatitis B virus-related hepatocellular carcinoma after curative treatments: A network meta-analysis
por: Xia, Zijing, et al.
Publicado: (2020)

Impact of COVID-19 Pandemic Waves on Outcomes of Patients with Previously Untreated Advanced Follicular Lymphoma Enrolled in the Urban Ambispective Study in Italy
por: Pinto, Antonio, et al.
Publicado: (2022)

Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
por: Ahn, Young-Hwan, et al.
Publicado: (2022)

Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review)
por: ZUO, CHAOHUI, et al.
Publicado: (2015)

Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas
por: Leslie, Lori A.
Publicado: (2021)

Antiviral therapy in acute viral hepatitis B: why and when
por: Morelli, Giuseppe, et al.
Publicado: (2009)

Antiviral therapy in acute viral hepatitis B: why and when
por: Morelli, Giuseppe, et al.
Publicado: (2009)

Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals
por: Huang, Chung-Feng, et al.
Publicado: (2018)

Hepatitis B: future curative strategies
por: Bertoletti, Antonio, et al.
Publicado: (2014)

Occult Hepatitis B Virus Infection in Patients With Chronic Hepatitis C Treated With Antiviral Therapy
por: Caviglia, Gian Paolo, et al.
Publicado: (2012)

Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections
por: Rehermann, Barbara, et al.
Publicado: (2015)

Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
por: Minson, Adrian, et al.
Publicado: (2022)

Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous Rituximab
por: Menzer, Christian, et al.
Publicado: (2022)

Current Antiviral Therapy for Chronic Hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2004)

Antiviral therapy for chronic hepatitis B in China
por: Zheng, Xin, et al.
Publicado: (2014)

The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis
por: Chen, Xu-Xiao, et al.
Publicado: (2017)

Indolent primary effusion lymphoma
por: Nagrale, Vidya, et al.
Publicado: (2020)

B‐cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non‐Hodgkin's Lymphoma
por: Gragnani, Laura, et al.
Publicado: (2022)

The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma
por: Chen, Yu-Syuan, et al.
Publicado: (2022)

microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus
por: Bruni, Roberto, et al.
Publicado: (2014)

Role of antibody-based therapy in indolent non-Hodgkin's lymphoma
por: Willard, Patrick, et al.
Publicado: (2021)

Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment
por: Imai, Kenji, et al.
Publicado: (2020)

Management of Hepatitis C Antiviral Therapy Adverse Effects
por: Sung, Hubert, et al.
Publicado: (2010)

Recent Advances in Antiviral Therapy for Chronic Hepatitis C
por: Tamori, Akihiro, et al.
Publicado: (2016)

Use of antiviral therapy in patients with chronic hepatitis C
por: Dragomiretskaya, Natalia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cq5pjrfqj6cc3cc1uo54gn5e4n